These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3661439

  • 1. Monotherapy with the calcium channel antagonist nisoldipine for systemic hypertension and comparison with diuretic drugs.
    Daniels AR, Opie LH.
    Am J Cardiol; 1987 Sep 15; 60(8):703-7. PubMed ID: 3661439
    [Abstract] [Full Text] [Related]

  • 2. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM.
    Lancet; 2000 Jul 29; 356(9227):366-72. PubMed ID: 10972368
    [Abstract] [Full Text] [Related]

  • 3. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR, Opie LH.
    Am J Cardiol; 1986 Apr 15; 57(11):965-70. PubMed ID: 3515899
    [Abstract] [Full Text] [Related]

  • 4. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K.
    J Cardiovasc Pharmacol; 2008 Jun 15; 51(6):590-5. PubMed ID: 18520951
    [Abstract] [Full Text] [Related]

  • 5. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H, Desche P.
    J Cardiovasc Pharmacol; 1991 Jun 15; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [Abstract] [Full Text] [Related]

  • 6. Rapid development of tolerance to the antihypertensive effect of nisoldipine.
    Ramsay LE, Waller PC.
    J Hum Hypertens; 1988 Mar 15; 1(4):277-80. PubMed ID: 3065506
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM, Soufer R, Hoffer P, Wackers FJ, Black HR.
    Am J Hypertens; 1996 Jun 15; 9(6):598-606. PubMed ID: 8783785
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.
    Brown MJ, Williams B, Morant SV, Webb DJ, Caulfield MJ, Cruickshank JK, Ford I, McInnes G, Sever P, Salsbury J, Mackenzie IS, Padmanabhan S, MacDonald TM, British Hypertension Society's Prevention and Treatment of Hypertension with Algorithm-based Therapy (PATHWAY) Studies Group.
    Lancet Diabetes Endocrinol; 2016 Feb 15; 4(2):136-47. PubMed ID: 26489809
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB, Jarvis B.
    Drugs; 2002 Feb 15; 62(5):787-816. PubMed ID: 11929332
    [Abstract] [Full Text] [Related]

  • 16. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 15; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hypertension in the very old.
    Otterstad JE, Ruilope LM.
    Int J Clin Pract Suppl; 2000 Nov 15; (114):10-9. PubMed ID: 11221289
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.
    Clin Drug Investig; 2007 Nov 15; 27(8):545-58. PubMed ID: 17638395
    [Abstract] [Full Text] [Related]

  • 19. Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
    Mancia G, Brown M, Castaigne A, de Leeuw P, Palmer CR, Rosenthal T, Wagener G, Ruilope LM, INSIGHT.
    Hypertension; 2003 Mar 15; 41(3):431-6. PubMed ID: 12623939
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.